Literature DB >> 12834270

Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria.

Yuu Ishida1, Izuki Bandou, Hiroki Kanzato, Naoyuki Yamamoto.   

Abstract

Different kinds of lactobacilli and Bifidobacteria fermented milk were fed to ovalbumin-specific IgE-elevated mice for 3 days, and after the final administration, changes in the ovalbumin-specific IgE values for each sample were compared to the value for non-fermented milk. Seven of the Lactobacillus-fermented milks caused a significant decrease in the serum ovalbumin-specific IgE levels. Above all, Lactobacillus acidophilus L92, Lactobacillus acidophilus CP1613, and Lactobacillus fermentum CP34 fermented milk had the most significant effects of decreasing the serum ovalbumin-specific IgE levels compared to a control group. The L. acidophilus L92 and L. fermentum CP34 cells also showed significant ovalbumin-specific IgE lowering activities. From these results, an active component seems to exist in the cells of L. acidophilus L92 and L. fermentum CP34 strains. Recovery of the radiolabeled L. acidophilus L92 and L. fermentum CP34 cells from the small intestine and the large intestine of the mouse 13 h after oral administration were higher than the recovery of any other strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834270     DOI: 10.1271/bbb.67.951

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  9 in total

1.  Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.

Authors:  N Takahashi; H Kitazawa; N Iwabuchi; J Z Xiao; K Miyaji; K Iwatsuki; T Saito
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Zizania latifolia and Its Major Compound Tricin Regulate Immune Responses in OVA-Treated Mice.

Authors:  Jae-Yeul Lee; Se-Ho Park; Kwang-Hwan Jhee; Seun-Ah Yang
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

Review 3.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

4.  Modulation of Immune Functions by Foods.

Authors:  Shuichi Kaminogawa; Masanobu Nanno
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

5.  Effects of Bifidobacterium bifidum G9-1 on Nasal Symptoms in a Guinea Pig Model of Experimental Allergic Rhinitis.

Authors:  Satoru Tsunemine; Yasuhiro Isa; Masaki Shimakawa; Hiroshi Ohno; Hideki Yamamura
Journal:  Biosci Microflora       Date:  2010-02-18

6.  Highly sensitive detection of influenza virus in saliva by real-time PCR method using sugar chain-immobilized gold nanoparticles; application to clinical studies.

Authors:  Yasuo Suda; Mami Nagatomo; Risa Yokoyama; Mami Ohzono; Kazue Aoyama; Xu Zhang; Kazuhiko Nakajima; Naoki Murakami; Tadashi Shinoda; Tatsuhiko Hirota; Sae Yanagihara; Jun-Ichiro Nishi
Journal:  Biotechnol Rep (Amst)       Date:  2015-05-19

7.  Polysaccharides L900/2 and L900/3 isolated from Lactobacillus rhamnosus LOCK 0900 modulate allergic sensitization to ovalbumin in a mouse model.

Authors:  Sabina Górska; Martin Schwarzer; Dagmar Srutkova; Petra Hermanova; Ewa Brzozowska; Hana Kozakova; Andrzej Gamian
Journal:  Microb Biotechnol       Date:  2017-02-06       Impact factor: 5.813

8.  Effects of lysed Enterococcus faecalis FK-23 on experimental allergic rhinitis in a murine model.

Authors:  Luping Zhu; Takashi Shimada; Ruoxi Chen; Meiping Lu; Qingzhao Zhang; Wenmin Lu; Min Yin; Tadao Enomoto; Lei Cheng
Journal:  J Biomed Res       Date:  2012-05-09

9.  Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice.

Authors:  Yosuke Kikuchi; Ayami Kunitoh-Asari; Katsuyuki Hayakawa; Shinjiro Imai; Kenji Kasuya; Kimio Abe; Yu Adachi; Shin-Ichi Fukudome; Yoshimasa Takahashi; Satoshi Hachimura
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.